These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25866609)

  • 1. Skin cancer in immunosuppressed transplant patients: Vigilance matters.
    Unlu O; Roach EC; Okoh A; Olayan M; Yilmaz B; Uzunaslan D; Shatnawei A
    World J Hepatol; 2015 Apr; 7(4):717-20. PubMed ID: 25866609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and risk factors of de novo skin cancer in the liver transplant recipients.
    Modaresi Esfeh J; Hanouneh IA; Dalal D; Tabba A; Lopez R; Pagadala M; Eghtesad B; Zein NN
    Int J Organ Transplant Med; 2012; 3(4):157-63. PubMed ID: 25013641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
    Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
    PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
    Dumortier J; Maucort-Boulch D; Poinsot D; Thimonier E; Chambon-Augoyard C; Ducroux E; Vallin M; Walter T; Robinson P; Guillaud O; Boillot O
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):427-435. PubMed ID: 29861393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease.
    Thimonier E; Guillaud O; Walter T; Decullier E; Vallin M; Boillot O; Dumortier J
    Clin Transplant; 2014 Dec; 28(12):1339-48. PubMed ID: 25081431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection predicts de novo hepatitis B infection in patients with alcoholic cirrhosis after liver transplantation.
    Xie M; Rao W; Yang T; Deng Y; Zheng H; Pan C; Liu Y; Shen Z; Jia J
    Liver Int; 2015 Mar; 35(3):897-904. PubMed ID: 24750566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.
    Mukthinuthalapati PK; Gotur R; Ghabril M
    World J Hepatol; 2016 Apr; 8(12):533-44. PubMed ID: 27134701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching to sirolimus monotherapy for de novo tumors after liver transplantation. A preliminary experience.
    Jiménez-Romero C; Manrique A; Marqués E; Calvo J; Sesma AG; Cambra F; Abradelo M; Sterup RM; Olivares S; Justo I; Colina F; Moreno E
    Hepatogastroenterology; 2011; 58(105):115-21. PubMed ID: 21510297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
    Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
    World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
    Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
    Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
    Kerkar N; Yanni G
    J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
    Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
    Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for alcoholic liver disease: Lessons learned and unresolved issues.
    Ursic-Bedoya J; Faure S; Donnadieu-Rigole H; Pageaux GP
    World J Gastroenterol; 2015 Oct; 21(39):10994-1002. PubMed ID: 26494956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative outcomes after liver transplantation in patients with alcoholic liver disease beyond the fifth post-transplant year.
    Grąt M; Lewandowski Z; Grąt K; Wronka KM; Krasnodębski M; Barski K; Zborowska H; Patkowski W; Zieniewicz K; Krawczyk M
    Clin Transplant; 2014 Oct; 28(10):1112-20. PubMed ID: 25059535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
    Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
    Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
    Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
    Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after the diagnosis of de novo malignancy in liver transplant recipients.
    Taborelli M; Piselli P; Ettorre GM; Baccarani U; Burra P; Lauro A; Galatioto L; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Rossi M; Tisone G; Zamboni F; Serraino D;
    Int J Cancer; 2019 Jan; 144(2):232-239. PubMed ID: 30091809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis.
    Duvoux C; Delacroix I; Richardet JP; Roudot-Thoraval F; Métreau JM; Fagniez PL; Dhumeaux D; Cherqui D
    Transplantation; 1999 Feb; 67(3):418-21. PubMed ID: 10030289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.
    Saigal S; Norris S; Muiesan P; Rela M; Heaton N; O'Grady J
    Liver Transpl; 2002 May; 8(5):482-7. PubMed ID: 12004349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center.
    Dumortier J; Guillaud O; Adham M; Boucaud C; Delafosse B; Bouffard Y; Paliard P; Scoazec JY; Boillot O
    Am J Gastroenterol; 2007 May; 102(5):1032-41. PubMed ID: 17313502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.